Lucas Ward
Stock Analyst at Ascendiant Capital
(0.72)
# 4,068
Out of 5,111 analysts
25
Total ratings
32%
Success rate
-30.14%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Maintains: Buy | $6.5 → $5.5 | $2.02 | +172.28% | 5 | Dec 3, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $3 → $2.8 | $0.82 | +241.42% | 4 | Nov 28, 2025 | |
| ACON Aclarion | Maintains: Buy | $22 → $23 | $6.11 | +276.43% | 5 | Nov 20, 2025 | |
| LIQT LiqTech International | Maintains: Buy | $4 → $4.2 | $1.85 | +127.29% | 6 | Nov 20, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $9 | $2.47 | +264.37% | 3 | Oct 1, 2025 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $0.38 | +710,239.38% | 2 | Jul 29, 2024 |
Vivos Therapeutics
Dec 3, 2025
Maintains: Buy
Price Target: $6.5 → $5.5
Current: $2.02
Upside: +172.28%
60 Degrees Pharmaceuticals
Nov 28, 2025
Maintains: Buy
Price Target: $3 → $2.8
Current: $0.82
Upside: +241.42%
Aclarion
Nov 20, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $6.11
Upside: +276.43%
LiqTech International
Nov 20, 2025
Maintains: Buy
Price Target: $4 → $4.2
Current: $1.85
Upside: +127.29%
HeartSciences
Oct 1, 2025
Maintains: Buy
Price Target: $15 → $9
Current: $2.47
Upside: +264.37%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $0.38
Upside: +710,239.38%